HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Fumoleau Selected Research

Viscum ribosome inactivating protein

2/2015A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials.
12/2004Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Fumoleau Research Topics

Disease

37Breast Neoplasms (Breast Cancer)
03/2017 - 10/2000
26Neoplasms (Cancer)
01/2017 - 01/2000
4Neutropenia
07/2007 - 11/2001
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2004 - 11/2001
3Glioma (Gliomas)
02/2015 - 09/2000
3Neoplasm Metastasis (Metastasis)
06/2013 - 07/2003
3Diarrhea
07/2007 - 08/2001
3Disease Progression
11/2006 - 11/2003
3Febrile Neutropenia
07/2004 - 08/2001
3Glioblastoma (Glioblastoma Multiforme)
12/2003 - 05/2002
3Stomach Neoplasms (Stomach Cancer)
06/2003 - 01/2000
3Stomatitis
02/2003 - 07/2001
3Asthenia
02/2003 - 07/2001
3Thrombocytopenia (Thrombopenia)
03/2002 - 08/2001
2Carcinoma (Carcinomatosis)
02/2015 - 06/2000
2Brain Neoplasms (Brain Tumor)
03/2010 - 09/2000
2Cardiotoxicity
03/2010 - 01/2006
2Melanoma (Melanoma, Malignant)
01/2005 - 01/2000
2Mucositis
01/2005 - 04/2003
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2004 - 11/2001
2Adenocarcinoma
11/2003 - 07/2003
2Colorectal Neoplasms (Colorectal Cancer)
02/2002 - 01/2002
2Head and Neck Neoplasms (Head and Neck Cancer)
12/2000 - 01/2000
1Pathologic Complete Response
01/2017
1Fibrosis (Cirrhosis)
06/2013
1Urinary Bladder Neoplasms (Bladder Cancer)
06/2013
1Liver Diseases (Liver Disease)
06/2013
1Unilateral Breast Neoplasms
10/2012
1Dysphonia (Spastic Dysphonia)
08/2012
1Proteinuria
08/2012
1Hypertension (High Blood Pressure)
08/2012
1Epistaxis (Nosebleed)
08/2012
1Bone Resorption
03/2012
1Hemic and Lymphatic Diseases
03/2010
1Left Ventricular Dysfunction
01/2006
1Leukemia
08/2005

Drug/Important Bio-Agent (IBA)

12Docetaxel (Taxotere)FDA Link
01/2016 - 12/2000
9AnthracyclinesIBA
10/2012 - 01/2001
8Vinorelbine (Navelbine)FDA LinkGeneric
02/2012 - 10/2000
7Trastuzumab (Herceptin)FDA Link
01/2017 - 03/2006
6taxaneIBA
10/2012 - 03/2004
6Epirubicin (Ellence)FDA LinkGeneric
11/2011 - 08/2001
4human ERBB2 proteinIBA
01/2017 - 03/2006
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2015 - 02/2001
4vinflunineIBA
06/2013 - 04/2003
4Taxoids (Taxanes)IBA
10/2012 - 07/2007
4Capecitabine (Xeloda)FDA Link
04/2012 - 03/2004
4Fluorouracil (Carac)FDA LinkGeneric
11/2011 - 02/2002
4N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA
01/2005 - 09/2001
4Leucovorin (Folinic Acid)FDA Link
08/2003 - 10/2000
3DNA (Deoxyribonucleic Acid)IBA
10/2012 - 05/2002
3GemcitabineFDA Link
05/2005 - 01/2001
3rubitecanIBA
08/2004 - 07/2002
3beta-D-glucosylisophosphoramide mustard (glufosfamide)IBA
03/2004 - 11/2003
3acridine DACAIBA
02/2003 - 01/2002
3SulfonamidesIBA
10/2002 - 09/2001
2Hormones (Hormone)IBA
03/2017 - 08/2006
2Viscum ribosome inactivating proteinIBA
02/2015 - 12/2004
2TubulinIBA
06/2013 - 11/2006
2Biomarkers (Surrogate Marker)IBA
10/2012 - 03/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012 - 06/2008
2Filgrastim (Neupogen)FDA Link
11/2011 - 02/2001
2Antineoplastic Agents (Antineoplastics)IBA
04/2007 - 10/2002
2Topoisomerase I InhibitorsIBA
08/2004 - 07/2002
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2003 - 02/2001
2TegafurIBA
07/2003 - 09/2001
2Type I DNA Topoisomerases (Topoisomerase I)IBA
02/2003 - 05/2002
2N'- (2- chloroethyl)- N- (2- (methylsulfonyl)ethyl)- N'- nitrosoureaIBA
09/2000 - 06/2000
1Ado-Trastuzumab EmtansineIBA
01/2016
1pertuzumabIBA
01/2016
1Heat-Shock Proteins (Heat-Shock Protein)IBA
05/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2015
1liposomal doxorubicin (Doxil)FDA Link
02/2015
1Progesterone Receptors (Progesterone Receptor)IBA
10/2012
1Phenobarbital (Luminal)FDA Link
10/2012
1Estrogen ReceptorsIBA
10/2012
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2012
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
10/2012
1Histone Deacetylase InhibitorsIBA
10/2012
1bosutinibIBA
03/2012
1Tyrosine Kinase InhibitorsIBA
03/2012
1Lapatinib (GW572016)FDA Link
02/2012
1ErbB Receptors (EGF Receptor)IBA
02/2012
1C 1311IBA
03/2010
1Monoclonal AntibodiesIBA
06/2008
1Bevacizumab (Avastin)FDA Link
06/2008
1Irinotecan (Camptosar)FDA LinkGeneric
06/2008
1Serotonin 5-HT3 Receptor AntagonistsIBA
08/2007
1Epothilones (Epothilone)IBA
07/2007
1epothilone B (EPO906)IBA
07/2007
1ixabepilone (BMS 247550)FDA Link
07/2007
1SR 271425IBA
04/2007
1TransferasesIBA
05/2005

Therapy/Procedure

28Drug Therapy (Chemotherapy)
01/2017 - 01/2000
8Therapeutics
03/2017 - 01/2001
7Neoadjuvant Therapy
06/2014 - 11/2003
7Adjuvant Chemotherapy
09/2013 - 02/2001
4Radiotherapy
02/2015 - 09/2000
2Mastectomy (Mammectomy)
10/2012 - 03/2006
2Intravenous Infusions
03/2004 - 08/2002